Mepicain Con Adrenalina (Epinephrine Bitartrate, Mepivacaine Hydrochloride)

Mepicain Con Adrenalina, a combination of a local anesthetic and a vasoconstrictor, is used for local infiltration anesthesia in minor surgical and dental procedures.

• Dental procedures: provides rapid onset anesthesia with prolonged duration for extractions, restorations and periodontal work.
• Minor skin surgery: enables effective local numbness for excisions, biopsies and suturing.
• Minor orthopedic procedures: facilitates analgesia for small joint injections and tendon repairs.

• Mepivacaine blocks voltage‑gated sodium channels on neuronal membranes, preventing depolarisation and impulse transmission. Epinephrine activates alpha‑adrenergic receptors on vascular smooth muscle, causing vasoconstriction that reduces local blood flow, limits systemic absorption of the anesthetic and extends its duration of action.

Adverse reactions may occur following infiltration with this combination product.

Common Side Effects

• Transient burning or stinging at the injection site.
• Mild dizziness or light‑headedness.
• Temporary increase in heart rate.
• Localised swelling or bruising.
• Nausea.
• Headache.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis) with rash, swelling and airway compromise.
• Cardiac arrhythmias or hypertension due to epinephrine excess.
• Prolonged numbness or paresthesia beyond the expected duration.
• Seizures from high plasma concentrations of local anesthetic.
• Methemoglobinemia (very rare).

Prior to use, clinicians should assess patient history and monitor for potential complications.

• Allergic history: verify no known hypersensitivity to amide‑type anesthetics or epinephrine.
• Cardiovascular disease: use cautiously in patients with uncontrolled hypertension or arrhythmias.
• Thyroid disorders: consider reduced tolerance to epinephrine effects.
• Pediatric use: dose must be calculated by the prescriber based on weight.
• Store at room temperature: keep in original container, protect from light and moisture.

Mepicain Con Adrenalina may interact with other agents that affect cardiovascular or nervous system function. Major Interactions (Avoid):\n- Non‑selective beta‑blockers: can potentiate epinephrine‑induced hypertension and tachycardia.

• Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis when combined with epinephrine.
• Class I anti‑arrhythmic drugs: may exacerbate cardiac conduction disturbances.

Moderate Interactions (Monitor Closely)

• Tricyclic antidepressants: may enhance local anesthetic toxicity.
• Diuretics: can alter plasma electrolyte balance, affecting anesthetic safety.
• Calcium channel blockers: may augment vasoconstrictive response.
• Other sympathomimetics: monitor blood pressure and heart rate.